- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) - dabigatran etexilate, apixaban and rivaroxaban2015 | First Faculty of Medicine
- Choosing patients for NOAC treatment: what to take into account?2015 | First Faculty of Medicine, Third Faculty of Medicine
- Monitoring of the efficacy of novel oral anticoagulants2014 | Second Faculty of Medicine
- Cost-effectiveness analysis of first-line NOAC prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation2019 | First Faculty of Medicine, Second Faculty of Medicine
- New direct oral anticoagulants (NOAC) - solutions to potential problems with coagulation assessment2014 | First Faculty of Medicine
- Haemorrhaging complications of anticoagulation therapy in geriatric patients2016 | Central Library of Charles University
- European Society of Cardiology Congress: News from the world of NOACs - "Diener's rule 1-3-6-12" and the first antidote with a proved effect2015 | Faculty of Medicine in Hradec Králové
- The issue of anticoagulation from a nephrologist's perspective2019 | First Faculty of Medicine
- Beriplex(R), four-factor prothrombin complex concentrate2016 | Publication without faculty affiliation
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Summary of the document prepared by the Czech Society of Cardiology2016 | Faculty of Medicine in Hradec Králové
- Doporučení pro bezpečnou léčbu novými perorálními antikoagulancii (NOAC)2015 | First Faculty of Medicine
- Perioperative care for patients with oral anticoagulants2018 | First Faculty of Medicine
- Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation2019 | Faculty of Medicine in Pilsen
- 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Translation of the document prepared by the Czech Society of Cardiology2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- What we expect from anticoagulant therapy in 20142014 | Publication without faculty affiliation
- News in the recommendation for pharmacotherapy of acute coronary syndromes without ST elevations2021 | Publication without faculty affiliation
- Anticoagulation 20132013 | Faculty of Medicine in Hradec Králové
- Spontaneous rebound of the anticoagulant effect of accumulated dabigatran after the antagonist activity cessation: Case report of life-threatening haemorrhage2018 | Third Faculty of Medicine
- Recent findings on new oral anticoagulants from the European Society of Cardiology Congress in Munich (25.-29. 8. 2012)2012 | First Faculty of Medicine
- Hemostasis and gastrointestinal bleeding2019 | Publication without faculty affiliation
- Lékové interakce u pacientů s onemocněním ledvin2019 | First Faculty of Medicine
- Management of a polymorbid patient with atrial fibrillation and renal insufficiency2019 | First Faculty of Medicine
- Medication adherence to non-vitamin K antagonist oral anticoagulants at non-valvular atrial fibrillation - the literature review +12017 | Faculty of Pharmacy in Hradec Králové
- New direct oral anticoagulants2016 | Publication without faculty affiliation
- Anticoagulation therapy in 20152015 | First Faculty of Medicine
- Anticoagulation therapy in 20152016 | Publication without faculty affiliation
- Anticoagulants in the treatment of deep vein thrombosis2013 | First Faculty of Medicine, Third Faculty of Medicine
- Pulmonary embolism in the practice2019 | Second Faculty of Medicine
- Bleeding complications of antithrombotic therapy - prevention is essential2020 | Publication without faculty affiliation
